132 related articles for article (PubMed ID: 38347558)
1. Pan-cancer characterization of cell-free immune-related miRNA identified as a robust biomarker for cancer diagnosis.
Wu P; Zhang C; Tang X; Li D; Zhang G; Zi X; Liu J; Yin E; Zhao J; Wang P; Wang L; Li R; Wu Y; Sun N; He J
Mol Cancer; 2024 Feb; 23(1):31. PubMed ID: 38347558
[TBL] [Abstract][Full Text] [Related]
2. Plasma microRNAs as potential new biomarkers for early detection of early gastric cancer.
Zhu XL; Ren LF; Wang HP; Bai ZT; Zhang L; Meng WB; Zhu KX; Ding FH; Miao L; Yan J; Wang YP; Liu YQ; Zhou WC; Li X
World J Gastroenterol; 2019 Apr; 25(13):1580-1591. PubMed ID: 30983818
[TBL] [Abstract][Full Text] [Related]
3. A novel combination of serum microRNAs for the detection of early gastric cancer.
Abe S; Matsuzaki J; Sudo K; Oda I; Katai H; Kato K; Takizawa S; Sakamoto H; Takeshita F; Niida S; Saito Y; Ochiya T
Gastric Cancer; 2021 Jul; 24(4):835-843. PubMed ID: 33743111
[TBL] [Abstract][Full Text] [Related]
4. Novel circulating microRNA signature as a potential non-invasive multi-marker test in ER-positive early-stage breast cancer: a case control study.
Kodahl AR; Lyng MB; Binder H; Cold S; Gravgaard K; Knoop AS; Ditzel HJ
Mol Oncol; 2014 Jul; 8(5):874-83. PubMed ID: 24694649
[TBL] [Abstract][Full Text] [Related]
5. Construction of a serum diagnostic signature based on m5C-related miRNAs for cancer detection.
Tang F; Liu Y; Sun Y; Xiong Y; Gu Y; Zhou J; Ouyang Y; Zhang S
Front Endocrinol (Lausanne); 2023; 14():1099703. PubMed ID: 36777349
[TBL] [Abstract][Full Text] [Related]
6. A circulating miRNA signature as a diagnostic biomarker for non-invasive early detection of breast cancer.
Zhang L; Xu Y; Jin X; Wang Z; Wu Y; Zhao D; Chen G; Li D; Wang X; Cao H; Xie Y; Liang Z
Breast Cancer Res Treat; 2015 Nov; 154(2):423-34. PubMed ID: 26476723
[TBL] [Abstract][Full Text] [Related]
7. A five-microRNA panel in plasma was identified as potential biomarker for early detection of gastric cancer.
Zhu C; Ren C; Han J; Ding Y; Du J; Dai N; Dai J; Ma H; Hu Z; Shen H; Xu Y; Jin G
Br J Cancer; 2014 Apr; 110(9):2291-9. PubMed ID: 24595006
[TBL] [Abstract][Full Text] [Related]
8. A unique circulating microRNA pairs signature serves as a superior tool for early diagnosis of pan-cancer.
Wu P; Li D; Zhang C; Dai B; Tang X; Liu J; Wu Y; Wang X; Shen A; Zhao J; Zi X; Li R; Sun N; He J
Cancer Lett; 2024 Apr; 588():216655. PubMed ID: 38460724
[TBL] [Abstract][Full Text] [Related]
9. Assessment of the Diagnostic Efficiency of a Liquid Biopsy Assay for Early Detection of Gastric Cancer.
Izumi D; Zhu Z; Chen Y; Toden S; Huo X; Kanda M; Ishimoto T; Gu D; Tan M; Kodera Y; Baba H; Li W; Chen J; Wang X; Goel A
JAMA Netw Open; 2021 Aug; 4(8):e2121129. PubMed ID: 34427680
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive circulating microRNA profile as a supersensitive biomarker for early-stage lung cancer screening.
Inagaki M; Uchiyama M; Yoshikawa-Kawabe K; Ito M; Murakami H; Gunji M; Minoshima M; Kohnoh T; Ito R; Kodama Y; Tanaka-Sakai M; Nakase A; Goto N; Tsushima Y; Mori S; Kozuka M; Otomo R; Hirai M; Fujino M; Yokoyama T
J Cancer Res Clin Oncol; 2023 Sep; 149(11):8297-8305. PubMed ID: 37076642
[TBL] [Abstract][Full Text] [Related]
11. Development of a Molecular Blood-Based Immune Signature Classifier as Biomarker for Risks Assessment in Lung Cancer Screening.
Fortunato O; Huber V; Segale M; Cova A; Vallacchi V; Squarcina P; Rivoltini L; Suatoni P; Sozzi G; Pastorino U; Boeri M
Cancer Epidemiol Biomarkers Prev; 2022 Nov; 31(11):2020-2029. PubMed ID: 36112827
[TBL] [Abstract][Full Text] [Related]
12. A serum microRNA classifier for early detection of hepatocellular carcinoma: a multicentre, retrospective, longitudinal biomarker identification study with a nested case-control study.
Lin XJ; Chong Y; Guo ZW; Xie C; Yang XJ; Zhang Q; Li SP; Xiong Y; Yuan Y; Min J; Jia WH; Jie Y; Chen MS; Chen MX; Fang JH; Zeng C; Zhang Y; Guo RP; Wu Y; Lin G; Zheng L; Zhuang SM
Lancet Oncol; 2015 Jul; 16(7):804-15. PubMed ID: 26088272
[TBL] [Abstract][Full Text] [Related]
13. Serum microRNA Signature Is Capable of Early Diagnosis for Non-Small Cell Lung Cancer.
Yang X; Zhang Q; Zhang M; Su W; Wang Z; Li Y; Zhang J; Beer DG; Yang S; Chen G
Int J Biol Sci; 2019; 15(8):1712-1722. PubMed ID: 31360113
[TBL] [Abstract][Full Text] [Related]
14. An miRNA signature associated with tumor mutation burden in endometrial cancer.
Zhou H; Chen L; Qin M; Lei Y; Li T; Li H; Cheng X
Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33141168
[TBL] [Abstract][Full Text] [Related]
15. Identification of a three-miRNA signature as a novel potential prognostic biomarker in patients with clear cell renal cell carcinoma.
Luo Y; Chen L; Wang G; Xiao Y; Ju L; Wang X
J Cell Biochem; 2019 Aug; 120(8):13751-13764. PubMed ID: 30957284
[TBL] [Abstract][Full Text] [Related]
16. miRNA-Based Feature Classifier Is Associated with Tumor Mutational Burden in Head and Neck Squamous Cell Carcinoma.
Xia Y; Wang Q; Huang X; Yin X; Song J; Ke Z; Duan X
Biomed Res Int; 2020; 2020():1686480. PubMed ID: 33490233
[TBL] [Abstract][Full Text] [Related]
17. Identification of two microRNA signatures in whole blood as novel biomarkers for diagnosis of nasopharyngeal carcinoma.
Wen W; Mai SJ; Lin HX; Zhang MY; Huang JL; Hua X; Lin C; Long ZQ; Lu ZJ; Sun XQ; Liu SL; Yang Q; Zhu Q; Wang HY; Guo L
J Transl Med; 2019 Jun; 17(1):186. PubMed ID: 31159814
[TBL] [Abstract][Full Text] [Related]
18. Genomewide Expression Profiling Identifies a Novel miRNA-based Signature for the Detection of Peritoneal Metastasis in Patients With Gastric Cancer.
Shimura T; Toden S; Kandimalla R; Toiyama Y; Okugawa Y; Kanda M; Baba H; Kodera Y; Kusunoki M; Goel A
Ann Surg; 2021 Nov; 274(5):e425-e434. PubMed ID: 31663973
[TBL] [Abstract][Full Text] [Related]
19. Potential circulating miRNA signature for early detection of NSCLC.
Arab A; Karimipoor M; Irani S; Kiani A; Zeinali S; Tafsiri E; Sheikhy K
Cancer Genet; 2017 Oct; 216-217():150-158. PubMed ID: 29025589
[TBL] [Abstract][Full Text] [Related]
20. An Exosome-based Transcriptomic Signature for Noninvasive, Early Detection of Patients With Pancreatic Ductal Adenocarcinoma: A Multicenter Cohort Study.
Nakamura K; Zhu Z; Roy S; Jun E; Han H; Munoz RM; Nishiwada S; Sharma G; Cridebring D; Zenhausern F; Kim S; Roe DJ; Darabi S; Han IW; Evans DB; Yamada S; Demeure MJ; Becerra C; Celinski SA; Borazanci E; Tsai S; Kodera Y; Park JO; Bolton JS; Wang X; Kim SC; Von Hoff D; Goel A
Gastroenterology; 2022 Nov; 163(5):1252-1266.e2. PubMed ID: 35850192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
